top of page

PRODUCT

With years of hands-on experience working with global leading clients, MicroMED has successfully transformed our innovative MEMS-enabled actuation technology into fully developed drug injection/infusion products. These products address emerging trends and unmet needs in subcutaneous and specialized drug delivery applications. They offer gentle, consistent, and powerful performance based on simple electrochemical principles and efficient energy transfer. The system enables precise control of flow rate and dose through linear or nonlinear actuation. Furthermore, the design is flexible and scalable, accommodating a wide range of dose volumes and viscosities. Additionally, it is both reusable and recyclable, while also capable of integrating connectivity features, allowing it to meet emerging sustainability and digitization/AI trends.

Home \ Product \ Primary Actuator®

Primary Actuator®

ISO 13485-certified/certifying product

MEMS Main Application

Home \ Product \ Preclinical Micropump

Preclinical Micropump

PM-160 Series

圖片2.jpg
潔霺生醫 A4 DM設計2 edited2 20240909-03-官網-02.jpg

PM-500 Series

圖片1.jpg
潔霺生醫 A4 DM設計2 edited2 20240909-03-官網-02.jpg

We have conducted a long-term implant safety test in 5 SPF rats at Mackay Hospital Biomedical Center.  Below is a summary for this safety test result:

[Method]

  • Implant for 7 days

  • Suture/clip site photo daily

  • Device explanted after 7 days

老鼠

[Observation]

  • 2 rats with hemorrhage on day 1 and recovered after day 4

  • No weight loss for all 5 rats

  • Tissue recovered well for all 5 rats after Day 5

  • Clip gives better heal than Suture

  • No rat shows significant effect and maintain good mobility during the whole testing period

Primary Actuator (ISO 13485-certified/certifying product)
Preclinical Micropump
shutterstock_1565185228.jpg
bottom of page